Heart Failure Clinical Trial
— PARTI-PARCOfficial title:
Research Into Factors Determining Participation in Two Interventions Modifying the Care Pathways of Patients With Heart Failure in Eastern Occitanie: PRADO-IC and Telemedicine
Patients with heart failure (HF), after hospitalization, present a marked fragility. Interventions improving the coordination of care actors at the time of discharge from hospitalization have been tested and have shown, in preliminary studies, a reduction in rehospitalizations for heart failure and all-cause mortality. Among these promising devices, two have recently been deployed nationwide. - The return home program for IC patients (PRADO IC), set up by the Health Insurance, aims to facilitate the return and stay at home after hospitalization. It offers assistance with the initiation of outpatient medical follow-up, nursing follow-up for 2 to 6 months depending on the severity of the patient, and a follow-up log facilitating the exchange of information. - At the same time, as part of the ETAPES (Telemedicine experiments for the improvement of healthcare pathways) program of the Health Insurance, the deployment of telemedicine for remote monitoring of heart failure pursues a comparable objective of reducing rehospitalizations. These two systems are widely deployed on a national scale, and are intended to be universal. Our hypothesis is that adherence to care transition and telemedicine programs, and therefore their effectiveness, may depend on their association, as well as socio-demographic, cultural, and geographical factors.
Status | Not yet recruiting |
Enrollment | 700 |
Est. completion date | September 1, 2025 |
Est. primary completion date | September 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patient - Patient hospitalized at the time of inclusion for cardiac decompensation, or cause of admission for which heart failure plays a decisive or aggravating role (co-infection, etc.) recognized by the clinician. - Patient agreeing to take part in this research (absence of non-objection) Exclusion Criteria: - Refusal to participate - Pregnant or breastfeeding women, patients unable to give protected adult consent, vulnerable people (art.L.1121-6, L.1121-7, L.1211-8, L.1211-9) - Subject deprived of liberty by judicial or administrative decision |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of patients participating in heart failure programs at 1 month | Participation corresponds to: for the PRADO group: visits to the attending physician and home nurses, and appointments made with the cardiologist for the remote monitoring group: completion of at least 80% of the weighings |
At 1 month | |
Primary | Percentage of patients participating in heart failure programs at 6 months | Participation corresponds to: for the PRADO group: visits to the attending physician and home nurses, and appointments made with the cardiologist for the remote monitoring group: completion of at least 80% of the weighings for the group without intervention: completion of the visit at 6 months |
At 6 months | |
Secondary | Number of non-participation of patients | Describe the causes of non-participation, primary (when the intervention was proposed) | At inclusion | |
Secondary | Number of non-participation of patients | Describe the causes of non-participation secondary (after initial acceptance) | through study completion, an average of 6 months | |
Secondary | Percentage effectiveness of pathology programs at 1 month | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on hospitalizations for all causes combined | between inclusion and 1 month | |
Secondary | Percentage effectiveness of pathology programs at 1 month | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on hospitalizations for heart failure | between inclusion and 1 month | |
Secondary | Percentage effectiveness of pathology programs at 1 month | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on deaths from all causes combined | between inclusion and 1 month | |
Secondary | Percentage effectiveness of pathology programs at 1 month | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on deaths due to heart failure | between inclusion and 1 month | |
Secondary | Percentage effectiveness of pathology programs at 6 months | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on hospitalizations for all causes combined | between inclusion and 6 months | |
Secondary | Percentage effectiveness of pathology programs at 6 months | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on hospitalizations for heart failure | between inclusion and 6 months | |
Secondary | Percentage effectiveness of pathology programs at 6 months | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on deaths from all causes combined | between inclusion and 6 months | |
Secondary | Percentage effectiveness of pathology programs at 6 months | Evaluate the effectiveness at 1 month of the PRADO and telemedicine programs, as well as their interaction, on deaths due to heart failure | between inclusion and 6 months | |
Secondary | percentage of effectiveness on the course of care at 6 months | Average number of consultations per month with the general practitioner | between inclusion and 6 months | |
Secondary | percentage of effectiveness on the course of care at 6 months | Time between the first consultation with the general practitioner and discharge from hospital | between inclusion and 6 months | |
Secondary | percentage of effectiveness on the course of care at 6 months | Average number of consultations per month with the cardiologist | between inclusion and 6 months | |
Secondary | percentage of effectiveness on the course of care at 6 months | Time between the first consultation with the cardiologist and discharge from hospital | between inclusion and 6 months | |
Secondary | percentage of days with at least one nursing contact | number of days with at least one nursing contact | between inclusion and 6 months | |
Secondary | Number of emergency medical contacts | are considered as emergency contacts: consultations with emergency increase, or increase for Night, Weekend or Public Holiday; consultations in emergencies; hospitalizations with emergency entry mode | between inclusion and 6 months | |
Secondary | percentage of medical appointments made | according to the continuity of care index, corresponding to the percentage of appointments made by patients with a doctor | between inclusion and 6 months | |
Secondary | Average number of treatment days taken per patient per month | For taking sartans treatments | between inclusion and 6 months | |
Secondary | Average number of treatment days taken per patient per month | For taking beta-blocker treatments | between inclusion and 6 months | |
Secondary | Average number of treatment days taken per patient per month | Coefficient of variation of the daily dose of loop diuretics, calculated as the average dose between two deliveries | between inclusion and 6 months | |
Secondary | percentage of efficiency on the cost of the care pathway at 6 months | Cost of care pathways: made up of production costs over 6 months after initial hospitalization, and includes all direct costs, whether medical or non-medical. | between inclusion and 6 months | |
Secondary | percentage of physicians offering heart failure programs | Beliefs of physicians on the facilitating elements and on the obstacles of these programs | between inclusion and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|